BofA Securities Maintains RxSight(RXST.US) With Buy Rating, Maintains Target Price $60

Futu NewsJan 7 14:32 · Ratings

Analysts' Top Healthcare Picks: RxSight (RXST), Pacific Biosciences (PACB)

TipRanksJan 7 13:40 · Ratings

RxSight, Inc. to Present at the J.P. Morgan Healthcare Conference

GlobeNewswireJan 3 05:05

RxSight, Inc.'s (NASDAQ:RXST) Stock Retreats 25% But Revenues Haven't Escaped The Attention Of Investors

Simply Wall StDec 26, 2024 18:00

Sector Update: Health Care Stocks Rise in Late Afternoon Trading

MT NewswiresDec 21, 2024 04:57

RxSight Shares Fall After Stifel Downgrade

MT NewswiresDec 21, 2024 04:00